Drug Resistant Profile among the Pulmonary Tuberculosis Patients at Waled General Hospital, Cirebon Regency, Indonesia
DOI:
https://doi.org/10.35898/ghmj-831236Keywords:
Drug Resistant Pulmonary Tuberculosis (DR-TB), Patient Profile, MDR-TB prevalence, ComorbiditiesAbstract
Background: Tuberculosis (TB) is an infectious bacterial disease caused by Mycobacterium tuberculosis, most commonly affecting the lungs. Drug Resistance Tuberculosis (DR-TB) is a TB disease resistant to one or more anti-tuberculosis drugs. In a global report in 2022, Indonesia ranked 5th for the burden of drug-resistant tuberculosis (DR-TB), and in the tuberculosis information system (SITB) data in West Java is one of the provinces with TB-RO case finding coverage that exceeds the national target with a percentage of 78%.
Aim: To determine the profile of drug-resistant pulmonary tuberculosis patients at Waled General Hospital, Cirebon Regency between 2022 and 2023.
Methods: This study used a retrospective descriptive method. Sampling was done using a total sampling technique, and a sample of 43 respondents was obtained. Data were collected through medical records and tuberculosis information system (SITB) and then analyzed by univariate statistics without comparisons or association tests.
Results: Based on socio-demographic characteristics, the majority of patients aged 46-55 years were 12(27.9%), patients with the most gender were male totaling 29(67.4%), patients with the most recent education were elementary school and high school had the same number of 15(34.9%), most patients' occupations were working at 32(74.4%). The most common classification of DR-TB is MDR-TB, totaling 35(81.4%), the history of previous tuberculosis treatment is mostly new patients at 18(41.3%), and most patients do not have comorbidities totaling 19(44.2%).
Conclusion: The profile of patients with DR-TB based on socio-demographics at Waled General Hospital, Cirebon between 2022 and 2023 is mainly aged 19-59 years with the most gender is male, the last education of elementary and high school has the same number, most patients work. Most patients with previous TB treatment histories were new, and most did not have comorbidities. A comprehensive approach to DR-TB control should incorporate; public education on treatment adherence, enhanced case management and surveillance, and consistent application of molecular diagnostics. Such measures may effectively decrease DR-TB prevalence and associated mortality. This study further highlights the importance of TB awareness and environmental hygiene in Indonesia's ongoing TB elimination efforts.
Downloads
References
Adejumo, O. A., Olusola-Faleye, B., Adepoju, V. A., Gidado, M., Onoh, M. O., Adegboye, O., Abdur-Razzaq, H., Moronfolu, O. & Shogbamimu, Y. (2020). The pattern of comorbidity and its prevalence among drug-resistant tuberculosis patients at treatment initiation in Lagos, Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 114(6), 415-423. https://doi.org/10.1093/trstmh/trz126
Aini, Z. M., & Rufia, N. M. (2019). Karakteristik Penderita Tuberculosis Multidrug Resistant (TB MDR) di Sulawesi Tenggara Tahun 2014-2017. Universitas Halu Oleo. https://dx.doi.org/10.52689/higea.v13i2.388
Al Qarni Bayan, U. (2022). Karakteristik Pasien Tuberkulosis Resistan Obat Di RSUD Dr. H. Chasan Boesoirie. Kieraha Medical Journal, 4(2), 116–123. https://doi.org/10.33387/kmj.v4i2.4651
Almaini, A., & Sutriyanti, Y. (2022). Studi Kualitatif Perilaku Pengobatan Pasien Tb Resisten Terhadap Obat Di Kabupaten Rejang Lebong. Journal Of Nursing and Public Health, 10(2), 77-87. https://doi.org/10.37676/jnph.v10i2.3137
Anderson, K., Pietersen, E., Shepherd, B. E., Bian, A., Dheda, K., Warren, R., Sterling, T. R. & van der Heijden, Y. F. (2022). High mortality among patients hospitalized for drug‐resistant tuberculosis with acquired second‐line drug resistance and high HIV prevalence. HIV medicine, 23(10), 1085-1097.. https://doi.org/10.1111/hiv.13318
Aristiana, C. D., & Wartono, M. (2018). Faktor-faktor yang mempengaruhi terjadinya Multi Drug Resistance Tuberkulosis (MDR-TB). Jurnal Biomedika Dan Kesehatan, 1(1). https://doi.org/10.18051/JBiomedKes.2018
Ayudhipasha, T. S., Herdwiyanti, M., & Sedayu, S. (2025). Correlation between Duration of Antiretroviral Therapy and Glomerular Filtration Rate in People Living with HIV/AIDS: A Cross-sectional Study in Cirebon, West Java, Indonesia. GHMJ (Global Health Management Journal), 8(1s), 95–101. https://doi.org/10.35898/ghmj-81s1182
Bakhtiar, M. I., Wiedyaningsih, C., Yasin, N. M., & Kristina, S. A. (2021). Hubungan karakteristik, kepatuhan, dan outcome klinis pasien tuberkulosis paru di puskesmas Kabupaten Bantul. Majalah Farmaseutik, 17(2), 256-269.. https://doi.org/10.22146/farmaseutik.v17i2.60681
Baluku, J. B., Nakazibwe, B., Naloka, J., Nabwana, M., Mwanja, S., Mulwana, R., Sempiira, M., Nassozi, S., Babirye, F., Namugenyi, C. Ntambi, S, Namiiro, S., Bongomin, F., Katuramu, R., Andia-Biraro, I., & Worodria, W. (2021). Treatment outcomes of drug resistant tuberculosis patients with multiple poor prognostic indicators in Uganda: a countrywide 5-year retrospective study. Journal of clinical tuberculosis and other mycobacterial diseases, 23, 100221. https://doi.org/10.1016/j.jctube.2021.100221
Damayanti, L., Widada, W., & Adi, G. S. (2022). Status Pengobatan Berhubungan Dengan Kejadian Tuberkulosis Resistan Obat Pada Usia Produktif. PROFESSIONAL HEALTH JOURNAL, 3(2), 138-148. https://doi.org/10.54832/phj.v3i2.197
Fachri, M., Fauzi, R. A., & Akaputra, R. (2021). Gambaran Radiologi Foto Toraks Pasien TB Paru Resistan Obat dengan dan Tanpa DM Tipe 2 di Rumah Sakit Islam Jakarta Sukapura. Jurnal Kedokteran Dan Kesehatan, 17(2), 177-186. https://doi.org/10.24853/jkk.17.2.177-186
Fatihah, H. B., Latief, M. A., & Herdwiyanti, M. (2025). Comparing Chest Radiograph Lesion Areas in Pulmonary Tuberculosis Patients with and without Diabetes Mellitus: A 2023 Study at Waled Hospital, Cirebon, Indonesia. GHMJ (Global Health Management Journal), 8(2), 166–171. https://doi.org/10.35898/ghmj-821161
Gelaw, Y., Getaneh, Z., & Melku, M. (2021). Anemia as a risk factor for tuberculosis: a systematic review and meta-analysis. Environmental health and preventive medicine, 26(1), 13. https://doi.org/10.1186/s12199-020-00931-z
Kementerian Kesehatan Indonesia. (2020). P. Petunjuk Teknis Penatalaksanaan Tuberkulosis Resistan Obat Di Indonesia. https://tbindonesia.or.id/wp-content/uploads/2021/06/TBRO_Buku-Juknis-Tuberkulosis-2020-Website.pdf
Khawbung, J. L., Nath, D., & Chakraborty, S. (2021). Drug resistant Tuberculosis: A review. Comparative immunology, microbiology and infectious diseases, 74, 101574. https://doi.org/10.1016/j.cimid.2020.101574
Kusumandari, V. P., Sunarti, S., & Nawangsari, D. (2023). Pengaruh Riwayat Pengobatan Pasien TB Terhadap Kejadian TB MDR di RSUD Prof. Dr. Margono Soekarjo. Pharmacy Genius, 2(3), 176-188. https://doi.org/10.56359/pharmgen.v2i3.294
Maksum, I. P., Suhaili, S., Amalia, R., Kamara, D. S., Rachman, S. D., & Rachman, R. W. (2018). PCR Multipleks untuk identifikasi Mycobacterium tuberculosis resisten terhadap isoniazid dan rifampisin pada galur lokal Balai Laboratorium Kesehatan Provinsi Jawa Barat. Jurnal Kimia Valensi, 4(2), 107-118. https://doi.org/10.15408/jkv.v4i2.7226
Mansur, M., Suprapti, B., Hidayati, M., Fatmawati, U. (2021). Gambaran Pemanjangan Interval Qtc Pada Terapi Jangka Pendek Pasien Tb Mdr. Studi Magister Farmasi Klinik. Surabaya. JURNAL MEDIA KESEHATAN, 14(1), 8–17. https://doi.org/10.33088/jmk.v14i1.581
Marfuati, S., Fitriani, H., Weni, M., & Riawan, F. P. (2024). Improving Pulmonary Tuberculosis Treatment Adherence: The role of patient knowledge in Cirebon, West Java, Indonesia. GHMJ (Global Health Management Journal), 7(2), 103–108. https://doi.org/10.35898/ghmj-72987
Muhammad, E. Y. (2019). Hubungan tingkat pendidikan terhadap kejadian tuberkulosis paru. Jurnal Ilmiah Kesehatan Sandi Husada, 8(2), 288-291. https://jurnalsandihusada.polsaka.ac.id/JIKSH/article/download/173/147
Muhammad, M., & Fadli, F. (2019). Analisis Faktor Penyebab Multi-Drug Resistance (Mdr) Pada Penderita Tuberkulosis. Jurnal Publikasi Kesehatan Masyarakat Indonesia, 6(2), 62-67. https://doi.org/10.20527/jpkmi.v6i2.7454
Oktaviyati, N., Pratamawati, T. M., & Nauphar, D. (2025). TNF-α −308 G/A Gene Polymorphism as a Risk Factor for Pulmonary Tuberculosis in Cirebon, Indonesia. GHMJ (Global Health Management Journal), 8(1s), 121–126. https://doi.org/10.35898/ghmj-81s1159
Purnamaningsih, I., Martini, M., Adi, M. S., & Saraswati, L. D. (2018). Hubungan Status Riwayat Kontak Bta+ Terhadapkejadian Tb Anak (Studi Di Balai Kesehatan Masyarakat Wilayah Semarang). Jurnal Kesehatan Masyarakat, 6(1), 273-278. https://doi.org/10.14710/jkm.v6i1.19881
Puspita, T., Suryatma, A., Simarmata, O. S., Veridona, G., Lestary, H., & Anwar, A. (2022). Spatial variation of tuberculosis risk in Indonesia 2010–2019. Health Science Journal of Indonesia, 12(2). https://doi.org/10.22435/hsji.v12i2.5467
Raini, M. (2016). Antibiotik golongan fluorokuinolon: Manfaat dan kerugian. Media Litbangkes, Vol. 26 No. 3, September 2016, 163-174. https://doi.org/10.22435/mpk.v26i3.4449.163-174
Reviono, Kusnanto, P., Eko, V., Pakiding, H., & Nurwidiasih, D. (2014). Multidrug resistant tuberculosis (MDR-TB): tinjauan epidemiologi dan faktor risiko efek samping obat anti tuberkulosis. Majalah Kedokteran Bandung, 46(4), 189-196. http://dx.doi.org/10.15395/mkb.v46n4.336
Sulaiman, S. C., Handayani, L., Suwandi, M. Y. S., & Soedarsono, S. (2018). Gambaran Radiografi Tuberkulosis Paru Multidrug-Resistant: Studi Retrospektif di Rumah Sakit Umum Dr. Soetomo Surabaya. Jurnal Respirasi, 4(3). https://doi.org/10.20473/jr.v4-I.3.2018.71-75
Sulistyawati, S., & Ramadhan, A. W. (2021). Risk Factors for Tuberculosis in an Urban Setting in Indonesia: A Case-control Study in Umbulharjo I, Yogyakarta. Journal of UOEH, 43(2), 165–171. https://doi.org/10.7888/juoeh.43.165
Thuraidah, A., Widya Astuti, R. A., & Rakhmina, D. (2017). Anemia dan Lama Konsumsi Obat Anti Tuberculosis. Medical Laboratory Technology Journal, 3(2), 42–46. https://doi.org/10.31964/mltj.v3i2.157
World Health Organization. (2018). Global Tuberculosis Report 2018. WHO. https://www.who.int/publications/i/item/9789241565646
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2025 Desy Syafira Santoso., S.Ked, Dwi Rosa Eka Agustina., dr., SP.P, Nihayatul Amaliyah., dr., Sp.PD
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
GHMJ (Global Health Management Journal) conforms fully to The Budapest Open Access Initiative (BOAI) and DOAJ Open Access Definition. Authors, readers, and reviewers are free to Share ” copy and redistribute the material in any medium or format, and Adapt ” remix, transform, and build upon the material. Author(s) retain unrestricted copyrights and publishing rights of their work. The licensor cannot revoke these freedoms as long as you follow the license terms. Learn the details at the License policy.
How to Cite
